Zweig-DiMenna Associates’s Zimmer Biomet ZBH Stock Holding History

Zweig-DiMenna Associates’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-29,314	Closed	-$3.74M	–	173
2018 Q3	$3.74M	Hold	29,314	–	–	0.31%	90
2018 Q2	$3.17M	Buy	+29,314	New	+$3.19M	0.19%	104

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Zweig-DiMenna Associates's ZBH Position: Q4 2018 in Review

Zweig-DiMenna Associates sold out of Zimmer Biomet (ZBH) in Q4 2018, closing a stake of 29,314 shares — an estimated $3.74M sold.

Zweig-DiMenna Associates first reported a position in ZBH in Q2 2018 and held it in 2 quarters. The position peaked at $3.74M in Q3 2018. 871 funds tracked by Wall St. Rank hold ZBH as of Q4 2018.

Zweig-DiMenna Associates reported no remaining Zimmer Biomet position as of Q4 2018 after selling out during the quarter.
Zweig-DiMenna Associates sold 29,314 Zimmer Biomet shares in Q4 2018, an estimated $3.74M.
Zweig-DiMenna Associates first reported a position in Zimmer Biomet in Q2 2018 and held it in 2 quarters.
Zweig-DiMenna Associates's Zimmer Biomet position peaked at $3.74M in Q3 2018.
871 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2018.

Based on Zweig-DiMenna Associates's 13F filing for Q4 2018, filed 25 Jan 2019.